Lawsuit Overview
July 24, 2015 (Shareholders Foundation) - An investor who currently holds shares of Receptos Inc (NASDAQ:RCPT), filed a lawsuit in effort to halt the proposed takeover of Receptos by Celgene Corporation for $232.00 per share. The plaintiff alleges that the defendants breached their fiduciary duties owed to NASDAQ:RCPT stockholders by agreeing to sell Receptos Inc too cheaply via an u...
You must register (for free) or login to view the entire case.